Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387663962> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4387663962 abstract "Abstract The dosage, efficacy and safety of Rituximab (RTX) in the treatment of proliferative lupus nephritis (PLN) have not been fully investigated. We collected the data episodes from January 2017 to July 2023 of patients with PLN who were hospitalized in the Department of Nephrology of the First Affiliated Hospital of Zhengzhou University and treated with RTX, and the renal remission, recurrence and adverse reactions after RTX treatment were analyzed retrospectively. A total of 22 patients were enrolled, including 7 patients who were treated as a naive and 15 relapsed/refractory patients, 4 patients required hemodialysis on admission. After the first treatment of RTX, a total of 21(95.45%) patients achieved B cell depletion, and a total of 15 patients (68.18%) achieved complete response (CR). The annual average frequency of relapse per individual in the maintenance remission period in 15 refractory/relapsing patients decreased from (0.494±0.346) times to (0.026±0.010) time (P<0.001), and the maintenance doses of prednisone decreased from (14.17±9.39) mg/day [ 20.0(12.3,40.0)months] to (8.67±5.97) mg/d[ 12.0(10.0,15.0)months] (P=0.040). Infection occurred in 3 patient within the first 3 months after RTX treatment and recovered after treatment, 3 cases were removed from hemodialysis, and no patient died. In conclusion, RTX can effectively treat PLN, reduce frequency of recurrences and decrease the dose of glucocorticoids, without increasing the occurrence of increased infection risks." @default.
- W4387663962 created "2023-10-17" @default.
- W4387663962 creator A5023287902 @default.
- W4387663962 creator A5033584583 @default.
- W4387663962 creator A5057733821 @default.
- W4387663962 creator A5060095131 @default.
- W4387663962 creator A5081451328 @default.
- W4387663962 creator A5082637623 @default.
- W4387663962 date "2023-10-16" @default.
- W4387663962 modified "2023-10-17" @default.
- W4387663962 title "Efficacy and safety of individualized rituximab in proliferative lupus nephritis" @default.
- W4387663962 doi "https://doi.org/10.21203/rs.3.rs-3406954/v1" @default.
- W4387663962 hasPublicationYear "2023" @default.
- W4387663962 type Work @default.
- W4387663962 citedByCount "0" @default.
- W4387663962 crossrefType "posted-content" @default.
- W4387663962 hasAuthorship W4387663962A5023287902 @default.
- W4387663962 hasAuthorship W4387663962A5033584583 @default.
- W4387663962 hasAuthorship W4387663962A5057733821 @default.
- W4387663962 hasAuthorship W4387663962A5060095131 @default.
- W4387663962 hasAuthorship W4387663962A5081451328 @default.
- W4387663962 hasAuthorship W4387663962A5082637623 @default.
- W4387663962 hasBestOaLocation W43876639621 @default.
- W4387663962 hasConcept C121332964 @default.
- W4387663962 hasConcept C126322002 @default.
- W4387663962 hasConcept C141071460 @default.
- W4387663962 hasConcept C142424586 @default.
- W4387663962 hasConcept C197934379 @default.
- W4387663962 hasConcept C2776694085 @default.
- W4387663962 hasConcept C2776755627 @default.
- W4387663962 hasConcept C2778063415 @default.
- W4387663962 hasConcept C2778720950 @default.
- W4387663962 hasConcept C2779134260 @default.
- W4387663962 hasConcept C2779338263 @default.
- W4387663962 hasConcept C2779912601 @default.
- W4387663962 hasConcept C2780653079 @default.
- W4387663962 hasConcept C3018657049 @default.
- W4387663962 hasConcept C54847362 @default.
- W4387663962 hasConcept C71924100 @default.
- W4387663962 hasConcept C87355193 @default.
- W4387663962 hasConcept C90924648 @default.
- W4387663962 hasConceptScore W4387663962C121332964 @default.
- W4387663962 hasConceptScore W4387663962C126322002 @default.
- W4387663962 hasConceptScore W4387663962C141071460 @default.
- W4387663962 hasConceptScore W4387663962C142424586 @default.
- W4387663962 hasConceptScore W4387663962C197934379 @default.
- W4387663962 hasConceptScore W4387663962C2776694085 @default.
- W4387663962 hasConceptScore W4387663962C2776755627 @default.
- W4387663962 hasConceptScore W4387663962C2778063415 @default.
- W4387663962 hasConceptScore W4387663962C2778720950 @default.
- W4387663962 hasConceptScore W4387663962C2779134260 @default.
- W4387663962 hasConceptScore W4387663962C2779338263 @default.
- W4387663962 hasConceptScore W4387663962C2779912601 @default.
- W4387663962 hasConceptScore W4387663962C2780653079 @default.
- W4387663962 hasConceptScore W4387663962C3018657049 @default.
- W4387663962 hasConceptScore W4387663962C54847362 @default.
- W4387663962 hasConceptScore W4387663962C71924100 @default.
- W4387663962 hasConceptScore W4387663962C87355193 @default.
- W4387663962 hasConceptScore W4387663962C90924648 @default.
- W4387663962 hasLocation W43876639621 @default.
- W4387663962 hasOpenAccess W4387663962 @default.
- W4387663962 hasPrimaryLocation W43876639621 @default.
- W4387663962 hasRelatedWork W152659163 @default.
- W4387663962 hasRelatedWork W1921119956 @default.
- W4387663962 hasRelatedWork W1991216872 @default.
- W4387663962 hasRelatedWork W2000792258 @default.
- W4387663962 hasRelatedWork W2394428917 @default.
- W4387663962 hasRelatedWork W2411583971 @default.
- W4387663962 hasRelatedWork W2781286807 @default.
- W4387663962 hasRelatedWork W31297289 @default.
- W4387663962 hasRelatedWork W3142333874 @default.
- W4387663962 hasRelatedWork W3082504439 @default.
- W4387663962 isParatext "false" @default.
- W4387663962 isRetracted "false" @default.
- W4387663962 workType "article" @default.